Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
72,412.32
(
-0.91%
)
News Focus
News Focus
Post# of 257388
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

io_io

Send PM Follow Ignore
Followers 63
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

io_io

Re: Praveen post# 20771

Monday, 12/19/2005 12:09:01 AM

Monday, December 19, 2005 12:09:01 AM

Post# of 257388
Praveen / TEVA

<<<"also MNTA is planning to file a biogeneric for copaxone(copaxone's patents have already expired), Also most of TEVA's revenues are from copaxone if I am right.....Short TEVA?">>>

I don't usually (hardly ever in fact) short a stock; OTOH I didn't know about this generic-Copaxone issue ...... I would suppose the Ranbaxy news is not good for generic-makers in general ?


"....on the biotech battle-field, you need some élan...."

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today